Antipruritic activity of the κ-opioid receptor agonist, TRK-820

European Journal of Pharmacology

Volumn 435, Issue 2-3, 2002, Pages 259-264

  Togashi, Yuko ^a   Umeuchi, Hideo ^a   Okano, Kiyoshi ^a   Ando, Naoki ^a   Yoshizawa, Yoshitaka ^a   Honda, Toshiyuki ^a   Kawamura, Kuniaki ^a   Endoh, Takashi ^a   Utsumi, Jun ^a   Kamei, Junzo ^b   Tanaka, Toshiaki ^a   Nagase, Hiroshi ^a  

^a TORAY INDUSTRIES INC   (Japan)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

Opioid receptor agonist; Itch; Pruritus; TRK 820

Indexed keywords

BINALTORPHIMINE; CHLORPHENIRAMINE; HISTAMINE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KETOTIFEN; NALFURAFINE; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PRURITUS; SCRATCHING;

ANIMALS; ANTIPRURITICS; CHLORPHENIRAMINE; DISEASE MODELS, ANIMAL; HISTAMINE; HISTAMINE H1 ANTAGONISTS; KETOTIFEN; MALE; MICE; MICE, INBRED ICR; MORPHINANS; MOTOR ACTIVITY; NALTREXONE; PRURITUS; RECEPTORS, OPIOID, KAPPA; SPIRO COMPOUNDS; SUBSTANCE P;

EID: 0037169176     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01588-6     Document Type: Article

References (34)

1. 1 tachykinin receptors in mice
2. Itching after epidural and spinal opiates
3. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis
4. Antipruritic effect of an opiate antagonist, naloxone hydrochloride
5. Intrathecal and epidural administration of opioids
6. Antagonism by opioids of compound 48/80-induced scratching in mice
7. Treatment of pruritus due to chronic obstructive liver disease
8. Substance P-induced histamine release in human cutaneous mast cells
9. Nor-binaltorphimine: A potent and selective κ-opioid receptor antagonist with long-lasting activity in vivo
10. Potent antinociceptive effects of TRK-820, a novel κ-opioid receptor agonist
11. Characterization of the antinociceptive effects of TRK-820 in the rat
12. TRK-820, a selective κ-opioid agonist, produces potent antinociception in cynomolgus monkeys
13. Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters
14. Role of opioid receptors in bombesin-induced grooming
15. Peripheral and central mediators of itch
16. Flare and itch induced by substance P in human skin
17. Mast-cell heterogeneity: Functional comparison of purified mouse cutaneous and peritoneal mast cells
18. 2 receptors in passive cutaneous anaphylaxis-induced scratching behavior in ICR mice
19. Norbinaltorphimine, a selective κ-opioid receptor antagonist, induces an itch-associated response in mice
20. Stereoselective antipruritic effects of enadoline and GR 94839 in mice
21. Different effects of antagonists to histamine and serotonin receptors on itch-related behavior induced by substance P, histamine and serotonin in mice
22. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice
23. Human mast cell heterogeneity: Histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli
24. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases
25. Interaction of RO 15-4513 and ethanol on the behaviour of mice: Antagonistic or additive effects?
26. Discovery of a structurally novel opioid κ-agonist derived from 4,5-epoxymorphinan
27. Randomised crossover trial of naltrexone in uraemic pruritus
28. Pruritus is dialysis patients: A neglected problem
29. Pharmacological properties of TRK-820 on cloned μ-, δ- and κ-opioid receptors and nociceptin receptor
30. 1 receptor antagonists on compound 48/80-induced scratching behavior in mice
31. A novel κ-opioid receptor agonist, TRK-820, blocks the development of physical dependence on morphine in mice
32. The novel κ-opioid receptor agonist TRK-820 has no effect on the development of antinociceptive tolerance to morphine in mice
33. The novel κ-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice
34. The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis